Stephen E. Jones, MD

home / authors / stephen-e-jones-md

Articles

Cost-Effectiveness of Docetaxel-Cyclophosphamide Versus Doxorubicin-Cyclophosphamide for Breast Cancer

Melissa F. Thompson, BSc, MBA;Lei Chen, MD, PhD;Muralikrishna Tangirala, MS, MPH;Lina Asmar, PhD;Stephen E. Jones, MD

October 1st 2011

Compared with doxorubicin plus cyclophosphamide, docetaxel plus cyclophosphamide was highly cost-effective for adjuvant treatment of operable breast cancer.

Published: October 23rd 2024 | Updated: October 24th 2024

What to Know About E Coli Outbreak Linked to McDonald’s Quarter Pounders

Published: January 18th 2016 | Updated: October 18th 2024

10 Pharmacy Quotes That Will Make You Rethink the Profession

Published: September 22nd 2015 | Updated: October 14th 2024

Gabapentin Differs From Pregabalin in Several Key Ways

Published: November 21st 2024 | Updated: November 23rd 2024

Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes

Published: August 30th 2024 | Updated: November 23rd 2024

Congress Requests Corrections to Testimony From Three Largest Pharmacy Benefit Manager Executives Following FTC Report

Published: October 8th 2024 | Updated: November 23rd 2024

What Drug Rates Are Reported in Price Transparency Data?

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Stephen E. Jones, MD

Articles

Latest Updated Articles